Arbutus Biopharma Corp (NASDAQ:ABUS)
| 1.14 Delayed Data As of Mar 30 |  -0.09 / -7.44%Today’s Change | 0.82 Today|||52-Week Range 4.56 | -58.99% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 1.21 |
| Today’s open | 1.29 |
| Day’s range | 1.10 - 1.29 |
| Volume | 2,102,409 |
| Average volume (3 months) | 739,612 |
| Market cap | $83.4M |
Data as of 7:39pm ET, 03/30/2020
Growth & Valuation
| Earnings growth (last year) | -137.84% |
| Earnings growth (this year) | +59.38% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +1.11% |
| P/E ratio | NM |
| Price/Sales | 26.40 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ADMSAdamas Pharmaceutica... | +0.09 | +3.37% |
| GNPXGenprex Inc | -0.20 | -7.78% |
| AQSTAquestive Therapeuti... | -0.02 | -0.87% |
| CYCNCyclerion Therapeuti... | -0.26 | -8.64% |
Data as of 7:45pm ET, 03/30/2020
Financials
| Next reporting date | April 30, 2020 |
| EPS forecast (this quarter) | -$0.31 |
| Annual revenue (last year) | $6.0M |
| Annual profit (last year) | -$153.7M |
| Net profit margin | -2,557.36% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
